← Leaderboards
Venugopalan Cheriyath
East Texas A&M University
$289,171
Attributed
$289,171
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $147.7K · FY2015–17$200K$150K$100K$50K$0
'15
'16
'17
Funding mix
By agency
NIH$289,171 · 2
By mechanism
R03$289,171 · 2
Top collaborators
No co-investigators on record.
Most similar at East Texas A&M University
Same institution · by research overlap
- Ben Jang$981,074
- Stephen D Starnes$879,021
- Robynne M Lock$452,485
- William G Newton$464,048
- Heungman Park$226,551
Others in their field
Top investigators on “Gene Activation”
- David Heimbrook · Leidos Biomedical Research, Inc.$214,546,841
- Gregory H Reaman · National Childhood Cancer Foundation$155,748,965
- Jeffrey P Krischer · University Of South Florida$145,540,434
- Julianne L Imperato-McGinley · Weill Medical College Of Cornell Univ$94,551,972
- Andrzej Joachimiak Joachimiak · University Of Chicago$85,074,308
- Peter B. Gilbert · Fred Hutchinson Cancer Center$68,989,136
Research focus
Gene ActivationInnovationCmv PromoterGain Of FunctionGeneticGenome-Wide AnalysisClinically RelevantClinical ResearchExhibitsFunctional GenomicsGenesGene TargetingGenomeGenome-WideAutomobile DrivingClinicBaseClinical PhenotypeDesignCellsCell TypeFunctional DisorderGene DiscoveryLibraries
Grant awards (4)
Target Identification and Validation to Overcome Antiestrogen Resistance in ER+ Breast Cancer$73,471
R03 · FY2017 · CA · contact PI
Myelodysplastic Syndrome Target Identification and Validation$79,700
R03 · FY2016 · CA · contact PI
Target Identification and Validation to Overcome Antiestrogen Resistance in ER+ Breast Cancer$68,000
R03 · FY2016 · CA · contact PI
Myelodysplastic Syndrome Target Identification and Validation$68,000
R03 · FY2015 · CA · contact PI